Page 83 - Haematologica March 2020

Cytokine blockade reduces myeloid expansion in RA
References
1. MyasoedovaE,CrowsonCS,KremersHM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62(6):1576-1582.
2. Birnbaum H, Pike C, Kaufman R, Marynchenko M, Kidolezi Y, Cifaldi M. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin. 2010;26(1):77-90.
3. Papadaki G, Kambas K, Choulaki C, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC mat- uration. Eur J Immunol. 2016;46(11):2542- 2554.
4. Firestein GS, Malnnes IB. Immuno- pathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183-196.
5. Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010;140(6):935- 950.
6. MorrisonSJ,ScaddenDT.Thebonemarrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327-334.
7. Pietras EM, Reynaud D, Kang Y-A, et al. Functionally distinct subsets of lineage- biased multipotent progenitors control blood production in normal and regenera- tive conditions. Cell Stem Cell. 2015;17 (1):35-46.
8. PietrasEM.Inflammation:akeyregulatorof hematopoietic stem cell fate in health and disease. Blood. 2017;130(15):1693-1698.
9. Manz MG, Boettcher S. Emergency granu- lopoiesis. Nat Rev Immunol. 2014;14(5):302- 314.
10. KingKY,GoodellMA.Inflammatorymodu- lation of HSCs: viewing the HSC as a foun- dation for the immune response. Nat Rev Immunol. 2011;11(10):685-692.
11. Colmegna I, Weyand CM. Haematopoietic stem and progenitor cells in rheumatoid arthritis. Rheumatology (Oxford). 2011;50(2):252-260.
12. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269-1275.
13. Ma YD, Park C, Zhao H, et al. Defects in osteoblast function but no changes in long- term repopulating potential of hematopoiet- ic stem cells in a mouse chronic inflammato- ry arthritis model. Blood. 2009;114 (20):4402-4410.
14. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement follow- ing anti-tumor necrosis factor-alpha antibody therapy. Blood. 2002;100(2):474-482.
15. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 2000; 97(16):9203-9208.
16. Pietras EM, Lakshminarasimhan R, Techner J-M, et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interfer- ons. J Exp Med. 2014;211(2):245-262.
17. Haas S, Hansson J, Klimmeck D, et al. In- flammation-induced emergency mega- karyopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell. 2015;17(4):422-434.
18. Gekas C, Graf T. CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood. 2013;121 (22):4463-4472.
19. Shaw AT, Gravallese EM. Mediators of inflammation and bone remodeling in rheu- matic disease. Semin Cell Dev Biol. 2016; 49:2-10.
20. Schepers K, Campbell TB, Passegué E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell. 2015;16(3):254-267.
21. Oduro KA, Liu F, Tan Q, Kim CK, et al. Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells. Blood. 2012;120 (11):2203-2213.
22. Challen GA, Boles NC, Chambers SM, Goodell MA. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF- 1. Cell Stem Cell. 2010;6(3):265-278.
23. Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle. 2009;8(8):1158-1160.
24. Ludin A, Gur-Cohen S, Golan K, et al. Reactive oxygen species regulate hematopoietic stem cell self-renewal, migra- tion and development, as well as their bone marrow microenvironment. Antioxid Redox Signal. 2014;21(11):1605-1619.
25. Pietras EM, Warr MR, Passegué E. Cell cycle regulation in hematopoietic stem cells. J Cell Biol. 2011;195 (5):709-20.
cells promotes proliferation but reduces competitive fitness. Cell Stem Cell. 2017;21 (2):225-225.
35. Pietras EM, Mirantes-Barbeito C, Fong S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards preco- cious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18(6): 607-618.
36. Hirai H, Zhang P, Dayaram T, et al. C/EBPbeta is required for “emergency” gran- ulopoiesis. Nat Immunol. 2006;7(7):732-739.
37. Libregts SF, Gutiérrez L, de Bruin AM, et al. Chronic IFN- production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood. 2011;118(9):2578- 2588.
38. Antony-Debré I, Paul A, Leite J, et al. Pharmacological inhibition of the transcrip- tion factor PU.1 in leukemia. J Clin Invest. 2017;127(12):4297-4313.
39. Colmegna I, Pryshchep S, Oishi H, Goronzy JJ, Weyand CM. Dampened ERK signaling in hematopoietic progenitor cells in rheuma- toid arthritis. Clin Immunol. 2012;143 (1):73-82.
40. Matatall KA, Jeong M, Chen S, et al. Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentia- tion. Cell Rep. 2016;17(10):2584-2595.
41. Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syn- dromes. Acta Haematol. 2016;136 (2):108-
26. Wilson A, Murphy MJ, Oskarsson T, et al. c- 117.
Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 2004;18(22): 2747-2763.
27. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
28. Rooney M, Symons JA, Duff GW. Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthri- tis. Rheumatol Int. 1990;10(5):217-219.
29. Karanikolas G, Charalambopoulos D, Vaiopoulos G, et al. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study. Rheumatology (Oxford). 2008;47(9):1384- 1388.
30. Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB. IL- 1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen- induced arthritis, whereas TNF-alpha block- ade only ameliorates joint inflammation. J Immunol. 1999;163(9):5049-5055.
31. Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH. Collagen-induced arthritis in B10.RIII mice (H-2r): identifica- tion of an arthritogenic T-cell determinant. Immunology. 1995;84(4):509-513.
32. van Den Berg WB, Joosten LA, van De Loo FA. TNF alpha and IL-1 beta are separate tar- gets in chronic arthritis. Clin Exp Rheumatol. 1999;17(6 Suppl 18):S105-114.
33. Papadaki HA, Marsh JCW, Eliopoulos GD. Bone marrow stem cells and stromal cells in autoimmune cytopenias. Leuk Lymphoma. 2002;43(4):753-760.
34. Takizawa H, Fritsch K, Kovtonyuk LV, et al. Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem
42. Bingham SJ, Snowden J, McGonagle D, et al. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients. J Rheumatol Suppl. 2001;64:21-24.
43. Kueh HY, Champhekar A, Champhekhar A, Nutt SL, Elowitz MB, Rothenberg EV. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science. 2013;341(6146):670-673.
44. Staber PB, Zhang P, Ye M, Welner RS, et al. Sustained PU.1 levels balance cell-cycle reg- ulators to prevent exhaustion of adult hematopoietic stem cells. Mol Cell. 2013;49(5):934-946.
45. Sun J, Ramos A, Chapman B, Johnnidis JB, Le L, Ho Y-J, et al. Clonal dynamics of native haematopoiesis. Nature. 2014;514(7522): 322-327.
46. Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM. Defective proliferative capacity and acceler- ated telomeric loss of hematopoietic progen- itor cells in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):990-1000.
47. Foudi A, Hochedlinger K, Van Buren D, et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol. 2008;27(1):84-90.
48. Wu T-C, Xu K, Martinek J, et al. IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer. Cancer Res. 2018;78(18):5243- 5258.
49. Brennan FM, Mcinnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537-3545.
50. Ridker PM, MacFadyen JG, Thuren T, et al. Effect of interleukin-1 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390 (10105):1833-1842.
haematologica | 2020; 105(3)
597